Connect with us

Health

BIOCAD will produce the COVID-19 vaccine developed by Gamalei Institute – EurekAlert

On September 23, 2020, the biotechnology company BIOCAD signed an agreement on the industrial production of the COVID-19 vaccine with the Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia named after V. Gamaleya. BIOCAD bec…

Published

on

post featured image

Clinical trials of the vaccine are currently underway. The &laquoSputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated introduction of a particle of coronavirus RNA, it is covered with a new adenovirus. This is done in order to exclude the presence of neutralizing antibodies against the vaccine in humans and thus enhance the reliability of repeated injection. The article on the &laquoSputnik V» vaccine was published b…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending